Skip to main content
Watch Insiders
PCSA filings

Corporate insider profile

David Young Filing Activity

Latest reported as Pres. Research & Development of Processa Pharmaceuticals, Inc. (PCSA).

Purchase filings
6
Reported companies
1
Net open-market value
$27,830
Latest transaction
Jun 30, 2026

Affiliated corporations

Reported company relationships

PCSALatest reported

Processa Pharmaceuticals, Inc.

Pres. Research & Development

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 30, 2026Processa Pharmaceuticals, Inc. (PCSA)Pres. Research & DevelopmentOpen Market Purchase2,531$1.93$4,885
Jun 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Pres. Research & DevelopmentOpen Market Purchase2,067$2.22$4,589
May 29, 2026Processa Pharmaceuticals, Inc. (PCSA)Pres. Research & DevelopmentOpen Market Purchase1,786$2.57$4,590
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium